Serina Therapeutics   Report issue

For profit Phase 1
Founded: Huntsville AL United States (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2016
NCT02579473
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now